RNXT
RenovoRx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.31
+1.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 35.45x
- P/S forward
- 7.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.58x
- Price / sales
- 29.92x
- Price / cash flow
- -4.98x
Enterprise value
- Enterprise value
- $49.9M
- EV / sales
- 25.25x
- EV / EBITDA
- -4.06x
- EV / EBIT
- -3.72x
- Market cap
- $59.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026